Company facts
- Industry
- Blank Checks
- Headquarters
- New York, New York
- Most recent report
- 10-Q, filed Aug 14, 2026
- Filings on record
- 45 filings
- On EDGAR
- CIK 2040475
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 4
News 8
Prospectuses and Registrations 5
- 424B4 Final prospectus for an offering Sep 25, 2025
- S-1/A Registration statement for an offering, amended Sep 16, 2025
- S-1/A Registration statement for an offering, amended Sep 15, 2025
- S-1/A Registration statement for an offering, amended Sep 5, 2025
- S-1 Registration statement for an offering Jul 21, 2025
Ownership 8 of 13
- 4 Insider reported a trade Oct 17, 2025
- 4 Insider reported a trade Oct 2, 2025
- SCHEDULE 13D Large holder reported an active stake Oct 2, 2025
- 4 Insider reported a trade Oct 1, 2025
- 4 Insider reported a trade Oct 1, 2025
- 4 Insider reported a trade Oct 1, 2025
- 4 Insider reported a trade Oct 1, 2025
- 3 Insider reported their initial holding Sep 25, 2025
Other 8 of 15
- NT 10-K Notice that an annual report will be late Apr 1, 2026
- NT 10-Q Notice that a quarterly report will be late Nov 17, 2025
- EFFECT Notice that a registration became effective Sep 24, 2025
- CERT Exchange certified a listing Sep 24, 2025
- 8-A12B Registration of a security for exchange listing Sep 24, 2025
- CORRESP Reply to SEC staff Sep 22, 2025
- CORRESP Reply to SEC staff Sep 22, 2025
- CORRESP Reply to SEC staff Sep 16, 2025
Everything here comes from Drugs Made In America Acquisition II Corp.'s own filings on SEC EDGAR. The filing list is rechecked every hour.